121 related articles for article (PubMed ID: 29549850)
1. Ketone bodies as a predictor of prognosis of hepatocellular carcinoma after transcatheter arterial chemoembolization.
Sasaki R; Taura N; Miyazoe Y; Yamamichi S; Nakashiki S; Yamashima M; Suehiro T; Honda T; Shibata H; Ozawa E; Miuma S; Akazawa Y; Miyaaki H; Matsumoto T; Nakao K; Ashizawa K
Nutrition; 2018 Jun; 50():97-103. PubMed ID: 29549850
[TBL] [Abstract][Full Text] [Related]
2. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients.
Huang YH; Wu JC; Chau GY; Lui WY; King KL; Chiang JH; Yen SH; Sheng WY; Hou MC; Lu CL; Chang FY; Lee SD
Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):315-21. PubMed ID: 10333206
[TBL] [Abstract][Full Text] [Related]
3. ABO Blood Group Differentials on Survival in Hepatocellular Carcinoma Patients Treated with Chemoembolization.
Bannangkoon K; Hongsakul K; Sripongpun P; Kaewdech A; Chamroonkul N; Tubtawee T; Piratvisuth T
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3685-3692. PubMed ID: 34837928
[TBL] [Abstract][Full Text] [Related]
4. Preoperative transarterial chemoembolization for hepatocellular carcinoma.
Kishi Y; Saiura A; Yamamoto J; Koga R; Seki M; Morimura R; Yoshioka R; Kokudo N; Yamaguchi T
Hepatogastroenterology; 2012 Oct; 59(119):2295-9. PubMed ID: 23435144
[TBL] [Abstract][Full Text] [Related]
5. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
6. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness.
Sergio A; Cristofori C; Cardin R; Pivetta G; Ragazzi R; Baldan A; Girardi L; Cillo U; Burra P; Giacomin A; Farinati F
Am J Gastroenterol; 2008 Apr; 103(4):914-21. PubMed ID: 18177453
[TBL] [Abstract][Full Text] [Related]
7. Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience.
Bettinger D; Spode R; Glaser N; Buettner N; Boettler T; Neumann-Haefelin C; Brunner TB; Gkika E; Maruschke L; Thimme R; Schultheiss M
BMC Gastroenterol; 2017 Aug; 17(1):98. PubMed ID: 28797231
[TBL] [Abstract][Full Text] [Related]
8. Renal failure in patients with hepatocellular carcinoma and ascites undergoing transarterial chemoembolization.
Hsu CY; Huang YH; Su CW; Lin HC; Chiang JH; Lee PC; Lee FY; Huo TI; Lee SD
Liver Int; 2010 Jan; 30(1):77-84. PubMed ID: 19818004
[TBL] [Abstract][Full Text] [Related]
9. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
[TBL] [Abstract][Full Text] [Related]
10. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.
Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C
Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999
[TBL] [Abstract][Full Text] [Related]
11. Serial serum VEGF-A, angiopoietin-2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization.
Hsieh MY; Lin ZY; Chuang WL
Kaohsiung J Med Sci; 2011 Aug; 27(8):314-22. PubMed ID: 21802642
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma.
Xu RC; Liu HC; Li JL; Li K; Ou SY; Yu ZY; Kong Y; Ma GA; Shao WS
Curr Med Res Opin; 2015 Aug; 31(8):1553-60. PubMed ID: 26067770
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors and model of primary liver cancer treated with transcatheter arterial chemoembolization combined with radiofrequency ablation].
Li J; Zhu WL; Kang XX; Zheng L; Guo CY; Yu P; Xiao JC
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):787-791. PubMed ID: 29061025
[No Abstract] [Full Text] [Related]
14. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY
J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991
[TBL] [Abstract][Full Text] [Related]
16. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis.
Hsu CY; Hsia CY; Huang YH; Su CW; Lin HC; Pai JT; Loong CC; Chiou YY; Lee RC; Lee FY; Huo TI; Lee SD
Ann Surg Oncol; 2012 Mar; 19(3):842-9. PubMed ID: 21913008
[TBL] [Abstract][Full Text] [Related]
17. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
18. Liver failure after transarterial chemoembolization for patients with hepatocellular carcinoma and ascites: incidence, risk factors, and prognostic prediction.
Hsin IF; Hsu CY; Huang HC; Huang YH; Lin HC; Lee RC; Chiang JH; Lee FY; Huo TI; Lee SD
J Clin Gastroenterol; 2011 Jul; 45(6):556-62. PubMed ID: 21666547
[TBL] [Abstract][Full Text] [Related]
19. Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization.
Prajapati HJ; Kim HS
PLoS One; 2017; 12(2):e0170750. PubMed ID: 28170405
[TBL] [Abstract][Full Text] [Related]
20. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
Shen J; Wang WS; Zhu XL; Ni CF
J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]